Literature DB >> 7628881

Preventive actions of Terminalia belerica in experimentally induced atherosclerosis.

H P Shaila1, A L Udupa, S L Udupa.   

Abstract

Hypercholesterolaemia and atherosclerosis were induced experimentally in rabbits by cholesterol feeding. The effect of an indigenous drug, T. belerica, was evaluated in these hypercholesterolemic rabbits. T. belerica reduced the levels of lipids in hypercholesterolemic animals. There was also a significant decrease in liver lipids and heart lipids (P < 0.05) in the drug-treated animals.

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7628881     DOI： 10.1016/0167-5273(95)02285-5

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


  4 in total

1.  Identification of novel anti-inflammatory agents from Ayurvedic medicine for prevention of chronic diseases: "reverse pharmacology" and "bedside to bench" approach.

Authors:  Bharat B Aggarwal; Sahdeo Prasad; Simone Reuter; Ramaswamy Kannappan; Vivek R Yadev; Byoungduck Park; Ji Hye Kim; Subash C Gupta; Kanokkarn Phromnoi; Chitra Sundaram; Seema Prasad; Madan M Chaturvedi; Bokyung Sung
Journal:  Curr Drug Targets       Date:  2011-10       Impact factor: 3.465

2.  Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice.

Authors:  Hiroko Makihara; Tsutomu Shimada; Eriko Machida; Masatomi Oota; Rika Nagamine; Masahito Tsubata; Kaoru Kinoshita; Kunio Takahashi; Masaki Aburada
Journal:  J Nat Med       Date:  2011-11-22       Impact factor: 2.343

Review 3.  Immunomodulatory effects of triphala and its individual constituents: a review.

Authors:  Pranoti Belapurkar; Pragya Goyal; Preeti Tiwari-Barua
Journal:  Indian J Pharm Sci       Date:  2014 Nov-Dec       Impact factor: 0.975

4.  Chemical composition, antioxidant and hepatoprotective activities of methanol extracts from leaves of Terminalia bellirica and Terminalia sericea (Combretaceae).

Authors:  Mansour Sobeh; Mona F Mahmoud; Rehab A Hasan; Mohamed A O Abdelfattah; Samir Osman; Harun-Or Rashid; Assem M El-Shazly; Michael Wink
Journal:  PeerJ       Date:  2019-02-27       Impact factor: 2.984
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.